Café

© 2026 Longbridge｜Terms of Service Privacy Policy

iShares Genomics Immunology and Healthcare ETF

IDNA

----

OverviewOverview OptionsOptions NewsNews PostsPosts WikiWiki RatingsRatings CompositionComposition DividendsDividends

LongbridgeAI

Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancer
PUBT·1 day ago, 03:11 PM
RVMD+0.57%
Earnings Preview: What To Expect From Moderna’s Report
Barchart Option·1 day ago, 06:48 AM
MRNA-4.45%MRNX-8.37%
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
prnewswire·2 days ago, 03:28 PM
ERAS+1.40%RVMD+0.57%
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price Target
Tip Ranks·1 day ago, 04:35 PM
RVMD+0.57%
Halozyme and Incyte sign licence agreement for INCA033989 formulations
Pharmaceutical Business Review·Jul 21 at 04:15 AM
INCY+1.11%HALO+1.55%
Moderna (MRNA) Stock Looks Above Fair Value After Cancer Trial News
Simplywall·7 hours ago
MRNA-4.45%MRNX-8.37%
FairJourney Bio Announces Scientific Program and Leadership for The Antibody Series 2026
MorningStar·Jul 21 at 04:04 AM
MRNA-4.45%MRNX-8.37%
Top Incyte Executives Quietly Lock In Profits With Fresh Stock Sales
Tip Ranks·Jul 20 at 09:01 PM
INCY+1.11%
Incyte EVP, Head of U.S. Commercial Issa Mohamed Khairie sells 1,093 shares for $125,705.93
PUBT·Jul 20 at 03:10 PM
INCY+1.11%
Moderna (MRNA) Adds Finance Veteran To Its Board, Is The Stock Fully Valued?
Simplywall·2 days ago, 08:14 AM
MRNA-4.45%MRNX-8.37%
Incyte Corp. Stock Outperforms Competitors On Strong Trading Day
MarketWatch Automated·2 days ago, 04:03 PM
INCY+1.11%
Incyte Corp. Stock Underperforms Monday When Compared To Competitors
MarketWatch Automated·Jul 20 at 04:04 PM
INCY+1.11%
Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers | INCY Stock News
StockTitan·Jul 17 at 04:10 AM
INCY+1.11%
S&P 500 Top Stock Gainers Today, 7/20/26
Tip Ranks·Jul 20 at 03:02 PM
MRNA-4.45%GOOG+0.22%
Trade Alert: Executive VP Of Incyte Steven Stein Has Sold Stock
Simplywall·Jul 18 at 08:10 AM
INCY+1.11%